Home>
US Stocks>
Aligos Therapeutics Inc

Aligos Therapeutics Inc share price today

(ALGS)

Aligos Therapeutics Inc share price is $28.67 & ₹2,426.71 as on 7 Dec 2024, 2.30 'hrs' IST

$28.67

▲

0.7

(2.5%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Aligos Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Aligos Therapeutics Inc from India. Also see the sentimental analysis on Indian investors investing in Aligos Therapeutics Inc. Get details on the Indian mutual funds that are investing in Aligos Therapeutics Inc. Get Analyst recommendations and forecasts along with all the Aligos Therapeutics Inc's financials.

Aligos Therapeutics Inc share price movements

$27.44
$30.27
$28.67
4.29%
Downside
Day's Volatility :9.36%
Upside
5.3%
$6.76
$30.00
$28.67
76.42%
Downside
52 Weeks Volatility :77.47%
Upside
4.43%

Aligos Therapeutics Inc Returns

Period	Aligos Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	43.95%	-5.7%	0.0%
6 Months	107.22%	-0.8%	0.0%
1 Year	92.9%	9.9%	0.0%
3 Years	-91.23%	10.7%	-19.7%

Aligos Therapeutics Inc Key Statistics

in dollars & INR

Previous Close	$27.97
Open	$28.82
Today's High	$30.274
Today's Low	$27.44
Market Capitalization	$92.5M
Today's Volume	$370.1K
52 Week High	$30.274
52 Week Low	$6.76
Revenue TTM	$6.0M
EBITDA	$-92.7M
Earnings Per Share (EPS)	$-6.99
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-146.69%

How to invest in Aligos Therapeutics Inc from India?

It is very easy for Indian residents to invest directly in Aligos Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aligos Therapeutics Inc stock in both rupees (INR) and dollars (USD). Search for Aligos Therapeutics Inc or ALGS on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aligos Therapeutics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aligos Therapeutics Inc shares which would translate to 0.030 fractional shares of Aligos Therapeutics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Aligos Therapeutics Inc

274%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Aligos Therapeutics Inc on INDmoney from India has grown in the last 30 days as on Dec 7, 2024. 274% more investors are searching Aligos Therapeutics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Aligos Therapeutics Inc

Armistice Capital, LLC
8.78%
EcoR1 Capital, LLC
7.12%
Deep Track Capital, LP
6.80%
Adage Capital Partners Gp LLC
6.10%
Vivo Capital, LLC
3.95%
Woodline Partners LP
2.56%

Analyst Recommendation on Aligos Therapeutics Inc

Buy

75%Buy

25%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Aligos Therapeutics Inc(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Aligos Therapeutics Inc

What analysts predicted

Upside of 260.42%

Current:

$28.67

Target:

$103.33

Insights on Aligos Therapeutics Inc

Increasing Revenue
Revenue is up for the last 3 quarters, 986.0K → 1.26M (in $), with an average increase of 11.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 5.06M → -19.25M (in $), with an average decrease of 480.5% per quarter
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.3% return, outperforming this stock by 133.5%

Aligos Therapeutics Inc Technicals Summary

Sell

Neutral

Buy

Aligos Therapeutics Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Aligos Therapeutics Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aligos Therapeutics Inc	199.14%	107.22%	92.9%	-91.23%	-92.47%
Regeneron Pharmaceuticals, Inc.	-5.97%	-23.34%	-8.6%	17.41%	110.02%
Biontech Se	11.44%	21.29%	14.9%	-59.29%	309.79%
Alnylam Pharmaceuticals, Inc.	-7.77%	64.08%	48.09%	42.33%	108.61%
Vertex Pharmaceuticals Incorporated	-6.83%	-4.83%	31.35%	122.6%	109.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aligos Therapeutics Inc	NA	NA	NA	-10.36	-1.47	-0.67	NA	15.07
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aligos Therapeutics Inc	Buy	$92.5M	-92.47%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	110.02%	18.56	33.61%
Biontech Se	Buy	$28.5B	309.79%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.61%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	109.65%	32.84	-4.51%

About Aligos Therapeutics Inc

aligos therapeutics, inc., a biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. its lead drug candidate is alg-010133, a synthetic oligonucleotide that is in phase i clinical trial for the treatment of chronic hepatitis b (chb). the company is also developing alg-000184, a capsid assembly modulator to treat chb; alg-020572, a oligonucleotide for the treatment of chb; alg-125097, an sirna drug candidate to treat chb; and alg-055009, a small molecule thr-ã agonist for the treatment of non-alcoholic steatohepatitis. aligos therapeutics, inc. was founded in 2018 and is headquartered in south san francisco, california.

Organization	Aligos Therapeutics Inc
Employees	68
CEO	Dr. Lawrence M. Blatt MBA, Ph.D.
Industry	Health Technology

Management People of Aligos Therapeutics Inc

Name	Title
Dr. Lawrence M. Blatt MBA, Ph.D.	CEO, President & Chairman of the Board
Dr. Julian A. Symons DPHIL	Executive VP & Chief Scientific Officer
Ms. Lesley Ann Calhoun CPA	Executive VP & CFO
Kristina Engeseth	VP and Head of People & Culture
Dr. Sushmita M. Chanda DABT, Ph.D.	Executive Vice President & Chief Development Officer
Dr. David B. Smith Ph.D.	Executive VP & Head of Chemical Operations
Dr. Tse-I Lin Ph.D.	VP of Early Compound Development & Belgian Site Head
Dr. Hardean E. Achneck M.D.	Chief Medical Officer

Important FAQs about investing in Aligos Therapeutics Inc from India :

What is Aligos Therapeutics Inc share price today?

Aligos Therapeutics Inc (ALGS) share price today is $28.67.

Can Indians buy Aligos Therapeutics Inc shares?

Yes, Indians can invest in the Aligos Therapeutics Inc (ALGS) from India.

With INDmoney, you can buy Aligos Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aligos Therapeutics Inc at zero transaction cost.

How can I buy Aligos Therapeutics Inc shares from India?

It is very easy to buy Aligos Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aligos Therapeutics Inc be purchased?

Yes, you can buy fractional shares of Aligos Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Aligos Therapeutics Inc stocks?

To start investing in Aligos Therapeutics Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.